# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-012333
Filing Date
2024-04-01
Accepted
2024-04-01 16:00:54
Documents
69
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1531900
2 |  | ex4-1.htm | EX-4.1 | 38711
3 |  | ex21-1.htm | EX-21.1 | 3428
4 |  | ex31-1.htm | EX-31.1 | 20331
5 |  | ex31-2.htm | EX-31.2 | 20456
6 |  | ex97.htm | EX-97.1 | 32111
7 |  | ex99-1.htm | EX-99.1 | 40876
8 |  | ex99-2.htm | EX-99.2 | 36113
9 |  | ex99-3.htm | EX-99.3 | 18330
10 |  | form10-k_001.jpg | GRAPHIC | 22820
11 |  | form10-k_002.jpg | GRAPHIC | 12061
12 |  | form10-k_003.jpg | GRAPHIC | 20362
13 |  | form10-k_004.jpg | GRAPHIC | 17245
| Complete submission text file | 0001493152-24-012333.txt |  | 5776579

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL SCHEMA FILE | ptix-20231231.xsd | EX-101.SCH | 34612
15 | XBRL CALCULATION FILE | ptix-20231231_cal.xml | EX-101.CAL | 46708
16 | XBRL DEFINITION FILE | ptix-20231231_def.xml | EX-101.DEF | 180874
17 | XBRL LABEL FILE | ptix-20231231_lab.xml | EX-101.LAB | 355513
18 | XBRL PRESENTATION FILE | ptix-20231231_pre.xml | EX-101.PRE | 278875
73 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 580870

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12555 | Film No.: 24808987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)